GENOMIC AND TRANSCRIPTOMIC CHARACTERIZATION OF MYELODYSPLASTIC SYNDROMES/MYELOPROLIFERATIVE NEOPLASMS

被引:0
|
作者
Acha, P. [1 ]
Ezponda, T. [2 ]
Vilas-Zornoza, A. [2 ]
Xicoy, B. [3 ]
Palomo, L. [4 ]
Fuster-Tormo, F. [4 ]
Manzanares, A. [1 ]
Zufiaurre, N. Berastegui [2 ]
Zamora, L. [5 ]
Jerez, A. [6 ]
Lopez-Cadenas, F. [7 ]
Diez-Campelo, M. [7 ]
Bonadies, N. [8 ,9 ]
Cervera-Zamora, J. [10 ]
Mascaro, M. [11 ]
Montoro, M. J. [4 ]
Hernandez, F. [12 ]
Raya, J. M. [13 ]
Ancin, I. [14 ]
Vahi, M. [15 ]
Garrastazul, M. P. [16 ]
Hermosin-Ramos, M. L. [17 ]
Mallo, M. [1 ]
Grau, J. [5 ]
Marce, S. [5 ]
Cabezon, M. [5 ]
Prosper, F. [2 ]
Sole, F. [1 ]
机构
[1] Univ Autonoma Barcelona, Myelodysplast Syndromes Res Grp, Hosp Germans Trias & Pujol, Josep Carreras Leukaemia Res Inst,ICO, Badalona, Spain
[2] Univ Navarra, CIMA, IDISNA, Area Oncol, Pamplona, Spain
[3] Hosp Badalona Germans Trias & Pujol, Hematol, Badalona, Spain
[4] Hosp Univ Vall dHebron, Vall Dhebron Inst Oncol Vhio, Barcelona, Spain
[5] Hosp Badalona Germans Trias & Pujol, ICO Badalona, Josep Carreras Leukemia Res Inst, Hematol Serv, Badalona, Spain
[6] Hosp Gen Univ Morales Meseguer, Dept Hematol, Murcia, Spain
[7] Hosp Univ Salamanca, Dept Hematol, Salamanca, Spain
[8] Univ Bern, Univ Hosp Bern, Dept Hematol, Inselspital, Bern, Switzerland
[9] Univ Bern, Univ Hosp Bern, Cent Hematol Lab, Inselspital, Bern, Switzerland
[10] Inst Invest Sanitaria La Fe, Dept Hematol, Valencia, Spain
[11] Hosp Univ Son Llatzer, Dept Hematol, Palma De Mallorca, Spain
[12] Hosp Univ Virgen de las Nieves, Dept Hematol, Granada, Spain
[13] Hosp Univ Canarias, Dept Hematol, Tenerife, Spain
[14] Hosp Univ Cruces, Dept Hematol, Vizcaya, Spain
[15] Hosp Univ Virgen de Valme, Dept Hematol, Seville, Spain
[16] Hosp Univ Puerta del Mar, Dept Hematol, Cadiz, Spain
[17] Hosp Jerez de la Frontera, Dept Hematol, Cadiz, Spain
关键词
D O I
10.1016/j.leukres.2023.107253
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P118
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
    Cazzola, Mario
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 349 - 352
  • [2] The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms
    Ragon, Brittany Knick
    Savona, Michael R.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S37 - S42
  • [3] Epidemiology of myeloproliferative neoplasms and myelodysplastic syndromes in Germany
    Kraywinkel, Klaus
    [J]. ONKOLOGE, 2019, 25 (11): : 948 - 956
  • [4] Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes
    Thota, Swapna
    Gerds, Aaron T.
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 803 - 812
  • [5] MOLECULAR ALTERATIONS ASSOCIATED WITH PROGRESSION OF MYELODYSPLASTIC SYNDROMES TO MYELODYSPLASTIC SYNDROMES/MYELOPROLIFERATIVE NEOPLASMS
    Valencia, A.
    Masala, E.
    Buchi, F.
    Sanna, A.
    Gozzini, A.
    Contini, E.
    Torricelli, F.
    Przychodzen, B.
    Maciejewski, J. P.
    Bosi, A.
    Santini, V.
    [J]. HAEMATOLOGICA, 2015, 100 : 54 - 54
  • [6] Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
    Xie, Wei
    Chen, Zhining
    Wang, So A.
    Hu, Shimin
    Li, Shaoying
    Miranda, Roberto N.
    Medeiros, L. Jeffrey
    Tang, Guiling
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 2993 - 3001
  • [7] Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
    Wan, Ziqi
    Han, Bing
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [8] Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes
    Tiu, Ramon V.
    Sekeres, Mikkael A.
    [J]. CURRENT OPINION IN HEMATOLOGY, 2014, 21 (02) : 131 - 140
  • [9] Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms
    Schnittger, S.
    Bacher, U.
    Haferlach, C.
    Alpermann, T.
    Dicker, F.
    Sundermann, J.
    Kern, W.
    Haferlach, T.
    [J]. LEUKEMIA, 2011, 25 (04) : 615 - 621
  • [10] Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms
    S Schnittger
    U Bacher
    C Haferlach
    T Alpermann
    F Dicker
    J Sundermann
    W Kern
    T Haferlach
    [J]. Leukemia, 2011, 25 : 615 - 621